AI in Pharma and Biotech Market Size, Share & Industry Analysis, By Technology (Machine Learning & Deep Learning, Natural Language Processing, and Others), By Application (Drug Discovery & Development, Clinical Research & Optimization, Precision Medicine, Pharmaceutical Manufacturing, Operations & Medical Affairs, and Others), By End User (Pharmaceutical & Biotechnology Companies, CDMOs & CROs, and Others), and Regional Forecast, 2026-2034

ATTRIBUTE

DETAILS

Study Period

2021-2034

Base Year

2025

Estimated Year

2026

Forecast Period

2026-2034

Historical Period

2021-2024

Growth Rate

CAGR of 43.55% from 2026-2034

Unit

Value (USD Billion)

Segmentation

By Technology, Application, End User, and Region

By Technology

·         Machine Learning & Deep Learning

·         Natural Language Processing

·         Others

By Application

·         Drug Discovery & Development

·         Clinical Research & Optimization

·         Precision Medicine

·         Pharmaceutical Manufacturing

·         Operations & Medical Affairs

·         Others

By End User

·         Pharmaceutical & Biotechnology Companies

·         CDMOs & CROs

·         Others

By Region

·         North America (By Technology, Application, End User, and Country)

o   U.S.

o   Canada

·         Europe (By Technology, Application, End User, and Country/Sub-region)

o   Germany

o   U.K.

o   France

o   Spain

o   Italy

o   Scandinavia

o   Rest of Europe

·         Asia Pacific (By Technology, Application, End User, and Country/Sub-region)

o   China

o   Japan

o   India

o   Australia

o   Southeast Asia

o   Rest of Asia Pacific

·         Latin America (By Technology, Application, End User, and Country/Sub-region)

o   Brazil

o   Mexico

o   Rest of Latin America

·         Middle East & Africa (By Technology, Application, End User, and Country/Sub-region)

o   GCC

o   South Africa

o   Rest of the Middle East & Africa